Epidermal growth factor-induced growth inhibition requires Stat1 activation

Cell Growth and Differentiation

Volumn 9, Issue 7, 1998, Pages 505-512

  Bromberg, Jacqueline F ^a   Fan, Zhen ^b   Brown, Carol ^c   Mendelsohn, John ^b   Darnell Jr , James E ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; STAT1 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; FIBROBLAST CULTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL CYCLE; CELL DIVISION; CELL LINE; DNA-BINDING PROTEINS; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLASTS; GROWTH INHIBITORS; HUMANS; INTERFERON TYPE II; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0031820158     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Ullrich, A., and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61: 203-212, 1990.
2. Gill, N. G., and Lazar, C. S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature (Lond.), 293: 305-307, 1981.
3. Barnes, D. W. Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free cell culture. J. Cell Biol., 93: 1-4, 1982.
4. Kawamoto, T., Mendelsohn, J., Le, A., Sato, G., Lazar, C., and Gill, G. Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J. Biol. Chem., 259: 7761-7766, 1984.
5. Filmus, J., Pollack, M. N., Cailleau, R., and Buick, R. N. MDA468, a human breast cancer cell line with a high number of EGF receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. Res. Commun., 128: 898-905, 1985.
6. Davidson, N. E., Gelman, E. P., Lippman, M. E., and Dickson, R. B. Epidermal growth factor receptor gene expression in estrogen receptor positive and negative human breast cancer cell lines. Mol. Endocrinol., 1: 216-223, 1987.
7. Gross, M. E., Zorbas, M. A., Daniels, Y. J., Garcia, R., Gallick, G. E., Olive, M., Brattain, M. G., Boman, B. M., and Yeoman, L. C. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. Cancer Res., 51: 1452-1459, 1991.
8. Fan, Z., Lu, Y., Wu, X., DeBlasio, A., Koff, A., and Mendelsohn, J. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J. Cell Biol., 131: 235-242, 1995.
9. Chin, Y. E., Kitagawa, M., Su, W. C., You, Z. H., Iwamoto, Y., and Fu, X. Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science (Washington DC), 272; 719-722, 1996.
10. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Canman, C. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, W. E., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
11. 1 arrest and apoptosis. Cancer Res., 12: 1169-1174, 1994.
12. Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak, T., Aizawa, S., Tokino, T., Oren, M., and Taniguchi, T. Cooperation of the tumour suppressors IRF1 and p53 in response to DNA damage. Nature (Lond.), 382: 816-818, 1996.
13. Schlessinger, J. Cellular signaling by receptor tyrosine kinases. Harvey Lect., 89: 105-123, 1993-1994.
14. Lemmon, M. A., and Schlessinger, J. Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem. Sci., 19: 459-463, 1994.
15. Schlessinger, J. SH2/SH3 signaling proteins. Curr. Opin. Genet. Dev., 4:25-30, 1994.
16. Fu, X-Y., and Zhang, J-J. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter. Cell, 74: 1135-1145, 1993.
17. Zhong, Z., Wen, Z., and Darnell, J. E., Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science (Washington DC), 264: 95-98, 1994.
18. Shuai, K., Ziemiecki, A., Wilks, A. F., Harpur, A. G., Sadowski, H. B., Gilman, M. Z., and Darnell, J. E., Jr. Polypeptide signaling to the nucleus through tyrosine phosphorylation of JAK and STAT proteins. Nature (Lond.), 366: 580-583, 1993.
19. Silvennoinen, O., Schindler, C., Schlessinger, J., and Levy, D. E. Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science (Washington DC), 267: 1736-1739, 1993.
20. Larner, A. C., David, M., Feldman, G. M., Igarashi, K-I., Hackett, R. H., Webb, D. S. A., Sweitzer, S. M., Petricon, E. F., III, and Finbloom, D. S. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science (Washington DC), 261: 1730-1733, 1993.
21. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. M. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Washington DC), 264: 1415-1421, 1994.
22. Darnell, J. E., Jr. STAT molecules and gene regulation. Science (Washington DC), 277: 1630-1635, 1997.
23. Leaman, D. W., Pisharody, S., Flickinger, T. W., Commane, M. A., Schlessinger, J., Kerr, I. M., Levy, D. E., and Stark, G. R. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol. Cell. Biol., 16: 369-375, 1996.
24. David, M., Wong, L., Flavell, R., Thompson, S. A., Wells, A., Larner, A. C., and Johnson, G. R. Stat Activation by EGF and amphiregulin-requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or Jak1. J. Biol. Chem., 277: 9185-9188, 1996.
25. Brown, C. L., Rubin, M., Masui, H., and Mendelsohn, J. Growth inhibition by anti-EGF receptor monoclonal antibody in squamous cervical carcinoma cells expressing TGF-α. Proc. Am. Assoc. Cancer Res., 35: 381, 1994.
26. Hollenberg, M. D., and Cuatrecasas, P. Insulin and epidermal growth factor Human fibroblast receptors related to deoxyribonucleic acid synthesis and amino acid uptake. J. Biol. Chem., 250: 3845-3853, 1975.
27. Carpenter, G., Lembach, K. J., Morrison, M. M., and Cohen, S. Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J. Biol. Chem., 250: 4297-4304, 1975.
28. Sadowski, H. B., Shuai, K., Darnell, J. E., Jr., and Gilman, M. Z. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science (Washington DC), 261: 1739-1744, 1993.
29. Shuai, K., Schindler, C., Prezioso, V. R., and Darnell, J. E., Jr. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91 kD DNA binding protein. Science (Washington DC), 259: 1808-1812, 1992.
30. Shuai, K., Horvath, C. M., Tsai-Huang, L. H., Qureshi, S., Cowburn, D., and Darnell, J. E., Jr. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell, 76: 821-828, 1994.
31. Sadowski, H. B., and Gilman, M. Z. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature (Lond.), 362: 79-83, 1993.
32. Pine, R., Canova, A., and Schindler, C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF1 promoter to mediate induction by IFN α and IFN γ, and is likely to autoregulate the p91 gene. EMBO J., 13: 158-167, 1994.
33. Muller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Jr., Stark, G. R., and Kerr, I. M. Complementation of a mutant cell line: central role of the 91 -kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathway. EMBO J., 12: 4221-4228, 1993.
34. Carpenter, G., and Cohen, S. 125-I labeled human epidermal growth factor. Binding, internalization and degradation in human fibroblasts. J. Cell Biol., 71: 159-171, 1976.
35. Carpenter, G., and Cohen, S. Human epidermal growth factor and the proliferation of human fibroblasts. J. Cell Physiol., 88: 227-237, 1976.
36. Masui, H., Castro, L., and Mendelsohn, J. Consumption of EGF by A431 cells: evidence for receptor recycling. J. Cell Biol., 120: 85-93, 1993.
37. Qureshi, S. A., Leung, S., Kerr, I. M., Stark, G. R., and Darnell, J. E., Jr. Function of Stat2 protein in transcriptional activation by IFN-α. Mol. Cell. Biol., 76: 288-293, 1996.
38. Nakajima, K., Yamanaka, Y., Nakae, K., Kojima, H., Ichiba, M., Kiuchi, N., Kitaoka, T., Fukada, T., Hibi, M., and Hirano, T. A central role for Stat3 in IL-6 induced regulation of growth and differentiation in M1 leukemia cells. EMBO J., 75: 3651-3658, 1996.
39. Minami, M., Inoue, M., Wei, S., Takeda, M., Matsumoto, M., Kishimoto, T., and Akira, S. Stat3 activation is a critical step in gp130 mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA, 93: 3963-3966, 1996.
40. Bromberg, J., Horvath, C. M., Wen, Z., Schreiber, R. D., and Darnell, J. E., Jr. Transcriptionally active Stat1 is required for the antiproliferative effects of both Interferon α and interferon gamma. Proc. Natl. Acad. Sci. USA, 93: 7673-7678, 1996.
41. Shuai, K., Liao, J., and Song, M. M. Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol. Cell. Biol., 16: 4932-4941, 1996.
42. Su, W. C. S., Kitagawa, M., Xue, N. R., Xie, B., Garofalo, S., Cho, J., Deng, C. X., Norton, W. A., and Fu, X. Y. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature (Lond.), 386: 288-292, 1997.
43. Coffer, P. J., and Kruijer, W. EGF receptor deletions define a region specifically mediating Stat transcription factor activation. Biochem. Biophys. Res. Commun., 270: 74-81, 1995.
44. Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Tamaguchi, T., Nakajima, K., and Hirano, T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of Stat3 in anti-apoptosis. Immunity, 5: 449-460, 1996.
45. Ausubel, F., Brent, R., Kingston, R. E., Moore, D., Seidman, J. G., Smith, J. A., and Struhl, K. Current Protocols in Molecular Biology, Vol. 1, Sect. 4 and 9. New York: John Wiley and Sons, 1994.
46. Shuai, K., Stark, G. R., Kerr, I. M., and Darnell, J. E., Jr. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science (Washington DC), 267: 1744-1746, 1993.
47. Wen, Z., Zhong, Z., and Darnell, J. E. J. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell, 82: 241-250, 1995.
48. Haspel, R. L., Salditt-Georgieff, M., and Darnell, J. E., Jr. The rapid inactivation of nuclear tyrosine phosphorylated Stat1 depends upon a protein tyrosine pnosphatase. EMBO J., 75: 6262-6268, 1996.
49. Levy, D. E., Kessler, D. S., Pine, R. I., and Darnell, J. E., Jr. Cytoplasmic activation of ISGF3, the positive regulator of interferon-a stimulated transcription, reconstituted in vitro. Genes Dev., 3: 1362-1372, 1989.
50. Fried, M., and Crothers, D. M. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res., 9: 6505-6525, 1981.
51. Schindler, C., Shuai, K., Prezioso, V. R., and Darnell, J. E., Jr. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science (Washington DC), 257: 809-815, 1992.